Menu

Telemedicine


10/24/23
Telemedicine Flexibilities Pertaining to Controlled Substances Extended Again!
Now the DEA and the Department of Health and Human Services have initiated a Second Temporary Rule to extend the expiration date to Dec. 31, 2024.
View
05/16/23
DEA Extends Telehealth Flexibility Pertaining to Controlled Substances
A pandemic-era policy that allows physicians to prescribe controlled substances in a telehealth visit has been extended to Nov. 11, 2023.
View
02/07/23
Free 18-Month Program Aims to Improve Cancer Diagnostics Via Telemedicine
To learn more, register for one of AHRQ’s informational webinars, available on numerous dates and times through May 2023.
View
10/05/21
Telemedicine Use Simmering Down After Explosive Increase
ISMIE offers a helpful primer on telemedicine for policyholders that outlines the key risk management considerations.
View

Cookie Consent

Cookies are required for some functionality on our site. View our privacy policy for more information.